Cizzle Biotechnology Holdings PLC (GB:CIZ)
LSE:CIZ
Want to see GB:CIZ full AI Analyst Report?
Total Valuation
Cizzle Biotechnology Holdings PLC has a market cap or net worth of £11.69M. The enterprise value is 12.42M .
Market Cap£11.69M
Enterprise Value12.42M
Share Statistics
Cizzle Biotechnology Holdings PLC has 424,963,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding424,963,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Cizzle Biotechnology Holdings PLC’s return on equity (ROE) is 2.03 and return on invested capital (ROIC) is 203.78%.
Return on Equity (ROE)2.03
Return on Assets (ROA)-2.82
Return on Invested Capital (ROIC)203.78%
Return on Capital Employed (ROCE)2.21
Revenue Per Employee0.00
Profits Per Employee-172.75K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cizzle Biotechnology Holdings PLC is ―. Cizzle Biotechnology Holdings PLC’s PEG ratio is 0.13.
PE Ratio―
PS Ratio0.00
PB Ratio-18.07
Price to Fair Value-18.07
Price to FCF-12.34
Price to Operating Cash Flow-21.98
PEG Ratio0.13
Income Statement
In the last 12 months, Cizzle Biotechnology Holdings PLC had revenue of 0.00 and earned -691.00K in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-753.00K
Pretax Income-751.00K
Net Income-691.00K
EBITDA-753.00K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -496.00K and capital expenditures -2.00K, giving a free cash flow of -498.00K billion.
Operating Cash Flow-496.00K
Free Cash Flow-498.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Cizzle Biotechnology Holdings PLC pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.46
52-Week Price Change57.14%
50-Day Moving Average2.67
200-Day Moving Average1.85
Relative Strength Index (RSI)45.27
Average Volume (3m)1.23M
Important Dates
Cizzle Biotechnology Holdings PLC upcoming earnings date is Sep 24, 2026, TBA (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateSep 24, 2026
Ex-Dividend Date―
Financial Position
Cizzle Biotechnology Holdings PLC as a current ratio of 0.42, with Debt / Equity ratio of 0.00%
Current Ratio0.42
Quick Ratio0.42
Debt to Market Cap0.00
Net Debt to EBITDA0.15
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Cizzle Biotechnology Holdings PLC has paid -60.00K in taxes.
Income Tax-60.00K
Effective Tax Rate0.08
Enterprise Valuation
Cizzle Biotechnology Holdings PLC EV to EBITDA ratio is -8.01, with an EV/FCF ratio of -12.10.
EV to Sales0.00
EV to EBITDA-8.01
EV to Free Cash Flow-12.10
EV to Operating Cash Flow-12.15
Balance Sheet
Cizzle Biotechnology Holdings PLC has £116.00K in cash and marketable securities with £0.00 in debt, giving a net cash position of £116.00K billion.
Cash & Marketable Securities£116.00K
Total Debt£0.00
Net Cash£116.00K
Net Cash Per Share<£0.01
Tangible Book Value Per Share>-£0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cizzle Biotechnology Holdings PLC is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast69.64%